BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$156M |
| 2 |
SPDR Gold Trust
GLD
|
+$142M |
| 3 |
Bank of America
BAC
|
+$107M |
| 4 |
iShares MSCI Brazil ETF
EWZ
|
+$92.9M |
| 5 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$81.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.53B |
| 2 |
Equinix
EQIX
|
+$2B |
| 3 |
Gilead Sciences
GILD
|
+$1.63B |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$1.48B |
| 5 |
United Therapeutics
UTHR
|
+$1.13B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 26.55% |
| 2 | Technology | 24.39% |
| 3 | Consumer Discretionary | 8.23% |
| 4 | Materials | 5.85% |
| 5 | Real Estate | 5.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EDE
2501
DELISTED
Empire District Electric
EDE
| $12.5K | ﹤0.01% |
553
-10,933
| -95% | -$246K |
|
2502
Stagwell
STGW
$2.28B
| $12.5K | ﹤0.01% |
+491
| New | +$10.6K |
|
2503
Clean Energy Fuels
CLNE
$395M
| $12.5K | ﹤0.01% |
969
-17,913
| -95% | -$219K |
|
2504
Titan International
TWI
$438M
| $12.5K | ﹤0.01% |
694
-14,052
| -95% | -$225K |
|
2505
TherapeuticsMD
TXMD
$24.1M
| $12.5K | ﹤0.01% |
48
-454
| -90% | -$99.4K |
|
|
ATMI
2506
DELISTED
A T M I INC
ATMI
| $12.5K | ﹤0.01% |
413
-8,227
| -95% | -$235K |
|
2507
Renasant Corp
RNST
$4B
| $12.5K | ﹤0.01% |
396
-8,018
| -95% | -$234K |
|
2508
Nelnet
NNI
$4.52B
| $12.4K | ﹤0.01% |
295
-6,013
| -95% | -$254K |
|
2509
Flotek Industries
FTK
$1.25B
| $12.4K | ﹤0.01% |
103
-2,083
| -95% | -$264K |
|
|
EPL
2510
DELISTED
EPL OIL & GAS, INC COMMON STK
EPL
| $12.4K | ﹤0.01% |
435
-7,857
| -95% | -$252K |
|
|
CTCT
2511
DELISTED
CONSTANT CONTACT, INC COM
CTCT
| $12.4K | ﹤0.01% |
+398
| New | +$10.5K |
|
2512
Novavax
NVAX
$1.34B
| $12.4K | ﹤0.01% |
121
-1,754
| -94% | -$124K |
|
2513
Sonic Automotive
SAH
$2.56B
| $12.4K | ﹤0.01% |
505
-10,224
| -95% | -$238K |
|
2514
Greenlight Captial
GLRE
$505M
| $12.3K | ﹤0.01% |
365
-7,282
| -95% | -$228K |
|
|
POZN
2515
DELISTED
POZEN INC
POZN
| $12.2K | ﹤0.01% |
+1,522
| New | +$10.8K |
|
|
ACO
2516
DELISTED
AMCOL International Corp
ACO
| $12.2K | ﹤0.01% |
360
-7,255
| -95% | -$233K |
|
|
BDBD
2517
DELISTED
BOULDER BRANDS INC
BDBD
| $12.2K | ﹤0.01% |
771
-15,269
| -95% | -$237K |
|
2518
Axos Financial
AX
$5.72B
| $12.2K | ﹤0.01% |
620
-12,700
| -95% | -$228K |
|
|
SN
2519
DELISTED
Sanchez Energy Corporation
SN
| $12.1K | ﹤0.01% |
494
-9,780
| -95% | -$260K |
|
2520
Ligand Pharmaceuticals
LGND
$5.76B
| $12.1K | ﹤0.01% |
369
-7,305
| -95% | -$238K |
|
|
TCF
2521
DELISTED
TCF Financial Corporation Common Stock
TCF
| $12.1K | ﹤0.01% |
382
-7,230
| -95% | -$216K |
|
|
MEAS
2522
DELISTED
MEASUREMENT SPECIALTIES INC
MEAS
| $12.1K | ﹤0.01% |
199
-4,126
| -95% | -$228K |
|
2523
EXL Service
EXLS
$5.36B
| $12.1K | ﹤0.01% |
2,185
-43,175
| -95% | -$236K |
|
|
FOE
2524
DELISTED
Ferro Corporation
FOE
| $12K | ﹤0.01% |
939
-18,851
| -95% | -$229K |
|
|
OVTI
2525
DELISTED
OMNIVISION TECHNOLOGIES INC
OVTI
| $12K | ﹤0.01% |
700
-13,842
| -95% | -$210K |
|
Similar funds
BNP Paribas Financial Markets's Q4 2013 Portfolio in Review
As of Q4 2013, BNP Paribas Financial Markets held 4,298 positions worth $137B, down 0.25% from $137B the previous quarter. Its ten largest holdings account for 38% of the portfolio.
BNP Paribas Financial Markets withdrew a net $60.2B in Q4 2013, closing 193 positions and reducing 1,811 holdings. Its most notable exit was Innoviva, an estimated $182M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 27% of assets, up from 17% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, BNP Paribas Financial Markets opened a new position in Ambev worth $22.5M.
- BNP Paribas Financial Markets's largest Q4 2013 buy was Ambev: 3,066,560 shares worth $22.5M.
- BNP Paribas Financial Markets added most to Apple in Q4 2013, an estimated $156M increase.
- BNP Paribas Financial Markets's biggest Q4 2013 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.53B.
- BNP Paribas Financial Markets fully exited Innoviva in Q4 2013, selling an estimated $182M.
- BNP Paribas Financial Markets's ten largest holdings make up 38% of its $137B portfolio in Q4 2013.
- BNP Paribas Financial Markets opened 1,712 new positions and closed 193 in Q4 2013.
- BNP Paribas Financial Markets's portfolio value fell 0.25% quarter-over-quarter to $137B.
Based on BNP Paribas Financial Markets's 13F filing for Q4 2013, filed 12 Feb 2014.